Log in
Enquire now
CardiaTec

CardiaTec

CardiaTec is an AI-powered cardiovascular drug discovery platform founded in 2021 by Thelma Zablocki, Raphael Peralta and Namshik Han.

OverviewStructured DataIssuesContributors

Contents

cardiatec.ai
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Cardiology
Cardiology
Artificial Intelligence (AI)
Artificial Intelligence (AI)
Drug discovery
Drug discovery
Pharmaceutical industry
Pharmaceutical industry
Health technology
Health technology
‌
Deep Tech
Biotechnology
Biotechnology
...
Location
United Kingdom
United Kingdom
B2X
B2B
B2B
CEO
‌
Raphael Peralta
Founder
‌
Namshik Han
‌
Thelma Zablocki
‌
Raphael Peralta
Number of Employees (Ranges)
1 – 10
Email Address
info@cardiatec.ai
Investors
Montage Ventures
Montage Ventures
APEX Ventures
APEX Ventures
‌
Continuum Health Ventures
LinkedIn
LinkedIn
‌
Laidlaw Foundation
Founded Date
January 1, 2021
Total Funding Amount (USD)
8,200,000
Latest Funding Round Date
September 10, 2024
CTO
‌
Namshik Han
Latest Funding Type
Seed
Seed
COO
‌
Thelma Zablocki
Country
United Kingdom
United Kingdom
Headquarters
Cambridge, Cambridgeshire
Cambridge, Cambridgeshire

Other attributes

Funding Type
Pre-Seed
Pre-Seed
Latest Funding Round Amount (USD)
6,500,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like CardiaTec

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.